lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
---|---|---|---|---|---|---|---|---|---|---|---|
ENST00000564834 | Influenza A virus (A_WSN_33 (H1N1) strain of IAV) | MOI = 1 ;
8 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | NCode™– Microarray | 2 | Upregulation | p < 0.01 | Rosetta Resolver Biosoftware, Build 7.2.2 SP1.31 (Rosetta Biosoftware) | one-sample t test | 2014 | 24440876 |
ENST00000564834 | Influenza A virus (A_WSN_33 (H1N1) strain of IAV) | MOI = 1 ;
8 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | Sureprint™ G3 Microarray | 2 | Upregulation | p < 0.01 | Rosetta Resolver Biosoftware, Build 7.2.2 SP1.31 (Rosetta Biosoftware) | one-sample t test | 2014 | 24440876 |
ENST00000564834 | Influenza A virus (A_WSN_33 (H1N1) strain of IAV) | MOI = 1 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | NCode™– Microarray | 4 | Upregulation | p < 0.01 | Rosetta Resolver Biosoftware, Build 7.2.2 SP1.31 (Rosetta Biosoftware) | one-sample t test | 2014 | 24440876 |
ENST00000564834 | Influenza A virus (A_WSN_33 (H1N1) strain of IAV) | MOI = 1 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | Sureprint™ G3 Microarray | 4 | Upregulation | p < 0.01 | Rosetta Resolver Biosoftware, Build 7.2.2 SP1.31 (Rosetta Biosoftware) | one-sample t test | 2014 | 24440876 |
ENSG00000261455 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Primary Human Bronchial epithelial (NHBE) cells | RNA-Seq | 0.33983295 | Downregulation | 0.001779407 | two-tailed t-test | 2020 | 32646047 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose